Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...

SAN DIEGO, CA / ACCESSWIRE / September 20, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testi ...

SciSparc submits IND application to US FDA for phase IIb trial for Tourette syndrome: Tel Aviv, Israel Friday, September 20, 2024, 17:30 Hrs [IST] SciSparc Ltd., a specialty clini ...

While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, ...

Three doctors have expressed concerns to Newsweek about weight loss drugs for children, with research suggesting an initial reluctance to prescribe them.

If you wish grocery stores were more expensive and offered less variety, then you’ll love his tariff proposal.

Whooping cough cases are climbing at the fastest pace in years as students across America return to school, U.S. heal ...

Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

Two Georgia mothers, Amber Thurman and Candi Miller, died in 2022 because of a lack of care most likely tied to the state’s ...

Targeting two receptors instead of the one targeted by fezolinetant, the new elinzanetant did not show the liver safety ...

Scans were taken starting three weeks before conception, through nine months of pregnancy and then two years postpartum. The study documented a widespread decrease in the volume of gray matter that ...

On Tuesday, a research team from Switzerland and several other nations published their findings in the new study, "Evidence for widespread human exposure to food contact chemicals ...